Moneycontrol PRO
Upcoming Webinar:Watch a panel of experts discuss: Challenges of continuously evolving regulation for Cryptocurrency, on 7th July at 3pm. Register Now
you are here: HomeNewsTrendsHealth

Coronavirus update | AIIMS experts say virus affects nearly all organs, patient classification system needs review

AIIMS director Dr Randeep Guleria said what we thought of as viral pneumonia has a lot of other manifestations which goes beyond the lungs

August 27, 2020 / 11:35 AM IST
Representative image

Representative image

SARS-Cov-2, the virus which causes COVID-19, can adversely affect nearly all organs in a human body, All India Institute of Medical Sciences (AIIMS) experts have said, highlighting the need to revisit the present system of classification of cases into mild, moderate and severe categories based solely on respiratory symptoms.

AIIMS experts, including director Dr Randeep Guleria, were discussing various possible extra-pulmonary complications of COVID-19 during the weekly 'National Clinical Grand Rounds', as per a PTI report.

The experts who participated in the programme cited several cases wherein patients were labelled as asymptomatic or mild but went on to develop serious life-threatening extra-pulmonary manifestations like stroke and heart blocks.

Dr Guleria said that a lot has been learnt since the COVID-19 outbreak occurred in March and accordingly strategies are being changed from time to time. From what we thought of as viral pneumonia has a lot of other manifestations which goes beyond the lungs, he said.

Track this LIVE blog for all the latest updates on coronavirus pandemic


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"As we have known more and more about COVID-19, we have realised it causes many extrapulmonary manifestations. This is basically of the fact that this virus enters into the cell through ACE2 receptors which although are present abundantly in upper airways and lungs, they are also present in many organs and thus other organs are also affected," PTI quoted Dr Guleria as saying.

We have seen many patients who presented with features which are not been predominantly pulmonary but extra-pulmonary manifestations, Dr Guleria added.

Also Read: Coronavirus vaccine update | Australian candidate shows promise; WHO says fair distribution of vaccine big challenge

"What started off as viral pneumonia is now a multi-systemic disease. However, the jury is out whether SARS-COV2 is the culprit or just an innocent bystander which happens to be at the wrong place at a wrong time," Dr Neeraj Nischal, Associate Professor in the Department of Medicine at AIIMS said, as per the report.

He further said that the classification of COVID-19 patients into mild, moderate and severe based only on respiratory symptoms should be "relooked into to incorporate other organ involvement".

(With inputs from PTI)

Click here for Moneycontrol's full coverage of the COVID-19
Moneycontrol News
first published: Aug 27, 2020 11:19 am
ISO 27001 - BSI Assurance Mark